Skip to main content
J

Jinhe Biotechnology CO.,LTD. — Investor Relations & Filings

Ticker · 002688 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,825 across all filing types
Latest filing 2025-10-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002688

About Jinhe Biotechnology CO.,LTD.

https://www.jinhe.com.cn

Jinhe Biotechnology CO.,LTD. specializes in the research, development, and manufacturing of animal health products and feed additives. The company is a prominent global producer of chlortetracycline (CTC), maintaining extensive production capacity for feed-grade antibiotics. Its diverse product portfolio includes veterinary pharmaceuticals such as salinomycin and monensin, alongside a range of biological products and animal vaccines. Jinhe Biotechnology leverages advanced fermentation technology and integrated research capabilities to provide solutions for the livestock and poultry sectors. The company focuses on improving animal growth performance and disease prevention through standardized production processes and a global distribution network. Its operations span the development of specialized additives and the provision of comprehensive veterinary medical products designed to support large-scale animal husbandry.

Recent filings

Filing Released Lang Actions
董事会薪酬与考核委员会议事规则
Regulatory Filings
2025-10-14 Chinese
关联交易决策制度
Regulatory Filings
2025-10-14 Chinese
年报信息披露重大差错责任追究制度
Regulatory Filings
2025-10-14 Chinese
第六届监事会第二十六次会议决议公告
Regulatory Filings
2025-10-14 Chinese
投资者关系管理制度
Regulatory Filings
2025-10-14 Chinese
重大经营与投资决策管理制度
Regulatory Filings
2025-10-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.